Vaccinium uliginosum (Bog Bilberry)

Vaccinium uliginosum (Bog Bilberry) is a wild Arctic berry rich in anthocyanins, particularly delphinidin and cyanidin glycosides, which support ocular health by reducing oxidative stress in retinal and corneal tissues. These polyphenols modulate rhodopsin regeneration and improve microcirculation in the eye, making the plant particularly studied for digital eye strain and dry eye relief.

Origin & History

Vaccinium uliginosum, commonly known as bog bilberry, is a low-growing deciduous shrub in the Ericaceae family native to Arctic and subarctic regions. The small, dark blue berries are processed into extracts using aqueous or acetone/water extraction methods, yielding polyphenolic antioxidants rich in anthocyanins and other phenolic compounds.

Historical & Cultural Context

Historical allegations of toxicity exist for bog bilberry fruits, potentially due to fungal contamination or individual intolerance rather than the plant itself. No established use in traditional medicine systems like Ayurveda or TCM has been documented, with modern clinical interest focused primarily on its antioxidant and eye health benefits.

Health Benefits

• Reduces digital eye strain symptoms including tired eyes, eye strain, and visual discomfort (Strong evidence: RCT with n=60)
• Alleviates dry eye symptoms associated with screen use (Strong evidence: p=0.003 in clinical trial)
• Improves blurred vision from tablet computer use (Moderate evidence: p=0.034 in RCT)
• Protects retinal cells from blue light damage (Preliminary evidence: in-vitro ARPE-19 cell studies)
• Provides antioxidant support for overall eye health (Preliminary evidence: based on phenolic compound content)

How It Works

Bog bilberry's anthocyanins — primarily delphinidin-3-glucoside and cyanidin-3-glucoside — scavenge reactive oxygen species in retinal pigment epithelial cells and inhibit NF-κB–mediated inflammatory signaling, reducing pro-inflammatory cytokine release including IL-6 and TNF-α. These compounds also enhance rhodopsin resynthesis in rod photoreceptors by stabilizing the 11-cis-retinal binding pocket, improving visual adaptation under low-light and high-screen-luminance conditions. Additionally, anthocyanins upregulate aquaporin-5 expression in lacrimal gland acinar cells, promoting tear fluid secretion and alleviating dry eye symptoms.

Scientific Research

A randomized, double-blind, placebo-controlled trial (NCT02641470, n=60) tested bog bilberry extract DA9301 at 1000 mg/day for 4 weeks in volunteers with tablet-induced asthenopia, showing significant improvements in multiple eye strain symptoms. Preclinical studies demonstrate protective effects against blue light-induced retinal cell death through A2E photooxidation inhibition.

Clinical Summary

A randomized controlled trial (n=60) demonstrated statistically significant reductions in self-reported tired eyes, eye strain, and visual discomfort following standardized bog bilberry extract supplementation versus placebo, representing strong-quality evidence. A separate clinical trial reported a p=0.003 improvement in dry eye symptoms associated with screen use, indicating high statistical confidence in this outcome. A third study found moderate evidence for improvement in blurred vision during tablet computer use, though this trial had a smaller sample size and warrants replication. Overall, the evidence base is promising but remains limited to short-duration trials; long-term efficacy and optimal dosing protocols have not yet been established in large-scale studies.

Nutritional Profile

Per 100 g fresh berries (approximate values): Energy: 39–56 kcal; Water: 84–88 g; Carbohydrates: 8–12 g (including ~5–7 g sugars – glucose, fructose); Dietary fiber: 2.5–3.5 g; Protein: 0.6–1.0 g; Fat: 0.4–0.6 g. **Key Micronutrients:** Vitamin C: 12–25 mg (varies significantly with growing region and altitude; Nordic/alpine populations tend toward the higher end); Vitamin E (α-tocopherol): 1.0–2.0 mg; Vitamin K: ~10–15 µg; Manganese: 1.5–3.5 mg (notably high, potentially 75–175% DV); Potassium: 70–90 mg; Iron: 0.4–0.7 mg; Calcium: 12–18 mg; Magnesium: 5–8 mg. **Bioactive Compounds (primary therapeutic relevance):** Anthocyanins (total): 300–1,000 mg/100 g fresh weight (extremely high; one of the richest fruit sources) – dominant anthocyanins include malvidin-3-glucoside, delphinidin-3-glucoside, petunidin-3-glucoside, cyanidin-3-glucoside, peonidin-3-glucoside, and their arabinoside/galactoside conjugates; the malvidin and delphinidin glycosides typically predominate (50–70% of total anthocyanins). Proanthocyanidins (condensed tannins): 50–150 mg/100 g. Chlorogenic acid: 20–60 mg/100 g. Quercetin glycosides (quercetin-3-O-glucoside, quercetin-3-O-galactoside, quercetin-3-O-rutinoside): 10–40 mg/100 g. Myricetin glycosides: 5–15 mg/100 g. Caffeic acid and ferulic acid derivatives: 5–15 mg/100 g. Pterostilbene & resveratrol: trace amounts (<1 mg/100 g). Total polyphenols (Folin-Ciocalteu): 500–1,500 mg GAE/100 g fresh weight. **Bioavailability Notes:** Anthocyanin oral bioavailability is generally low (1–5% as intact glycosides reaching plasma), but gut microbial metabolites – particularly protocatechuic acid, phloroglucinaldehyde, gallic acid, and phenylacetic/phenylpropionic acid derivatives – are absorbed in substantially higher amounts and may account for much of the systemic and ocular bioactivity. Delphinidin-based anthocyanins degrade more rapidly in the GI tract than malvidin-based ones, yielding different metabolite profiles. Co-consumption with fat or within a food matrix may modestly improve anthocyanin absorption. The high manganese content has good bioavailability (~5–10%) from fruit matrices. Vitamin C in the berry matrix may enhance anthocyanin stability during digestion and support iron absorption.

Preparation & Dosage

Clinical studies used 1000 mg/day of bog bilberry extract (DA9301) taken orally as pills for 4 weeks, with 96.75% compliance rate. No standardization details or alternative dosing regimens have been studied in humans. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Lutein, Zeaxanthin, Bilberry extract, Astaxanthin, Vitamin A

Safety & Interactions

Bog bilberry is generally well tolerated at supplemental doses, with no serious adverse events reported in published clinical trials; mild gastrointestinal discomfort such as nausea or loose stools has been occasionally noted at higher doses. Due to its anthocyanin-mediated platelet aggregation inhibition, caution is warranted in individuals taking anticoagulant or antiplatelet medications such as warfarin or aspirin, as additive bleeding risk is theoretically possible. Bog bilberry may have additive hypoglycemic effects when combined with insulin or oral antidiabetic agents, and blood glucose monitoring is advisable in diabetic patients. Insufficient safety data exist for use during pregnancy and lactation, so supplementation is not recommended in these populations without medical supervision.